376 related articles for article (PubMed ID: 16871230)
21. Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa.
Pulkkinen L; Cserhalmi-Friedman PB; Tang M; Ryan MC; Uitto J; Christiano AM
Lab Invest; 1998 Sep; 78(9):1067-76. PubMed ID: 9759651
[TBL] [Abstract][Full Text] [Related]
22. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
23. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa.
Pulkkinen L; Christiano AM; Gerecke D; Wagman DW; Burgeson RE; Pittelkow MR; Uitto J
Genomics; 1994 Nov; 24(2):357-60. PubMed ID: 7698759
[TBL] [Abstract][Full Text] [Related]
24. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
[TBL] [Abstract][Full Text] [Related]
25. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.
Voutetakis A; Bossis I; Kok MR; Zhang W; Wang J; Cotrim AP; Zheng C; Chiorini JA; Nieman LK; Baum BJ
J Endocrinol; 2005 Jun; 185(3):363-72. PubMed ID: 15930162
[TBL] [Abstract][Full Text] [Related]
26. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
[TBL] [Abstract][Full Text] [Related]
27. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration.
Bostick B; Ghosh A; Yue Y; Long C; Duan D
Gene Ther; 2007 Nov; 14(22):1605-9. PubMed ID: 17898796
[TBL] [Abstract][Full Text] [Related]
28. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
29. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
30. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus.
Douar AM; Adebakin S; Themis M; Pavirani A; Cook T; Coutelle C
Gene Ther; 1997 Sep; 4(9):883-90. PubMed ID: 9349424
[TBL] [Abstract][Full Text] [Related]
31. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
[TBL] [Abstract][Full Text] [Related]
33. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
34. Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa.
Meng X; Klement JF; Leperi DA; Birk DE; Sasaki T; Timpl R; Uitto J; Pulkkinen L
J Invest Dermatol; 2003 Oct; 121(4):720-31. PubMed ID: 14632187
[TBL] [Abstract][Full Text] [Related]
35. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
[TBL] [Abstract][Full Text] [Related]
36. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
37. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Calos MP; Khavari PA
Hum Gene Ther; 2003 Jun; 14(9):923-8. PubMed ID: 12828862
[TBL] [Abstract][Full Text] [Related]
38. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.
Sumner-Jones SG; Davies LA; Varathalingam A; Gill DR; Hyde SC
Gene Ther; 2006 Dec; 13(24):1703-13. PubMed ID: 16855618
[TBL] [Abstract][Full Text] [Related]
39. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
[TBL] [Abstract][Full Text] [Related]
40. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Koeberl DD; Sun BD; Damodaran TV; Brown T; Millington DS; Benjamin DK; Bird A; Schneider A; Hillman S; Jackson M; Beaty RM; Chen YT
Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
